BioSpace News Archive

Press Releases

Imviva Biotech Announces Acceptance of Late-Breaking Abstract Highlighting Data from Ongoing Phase 1/2 Study of CTA313 at 15th European Lupus Meeting

March 2, 2026
·
4 min read
Press Releases

CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting

March 2, 2026
·
4 min read
Press Releases

FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis

March 2, 2026
·
5 min read
Press Releases

Biomimetic Innovations Ltd Announces Upcoming Clinical Study of OsStic™ Injectable Synthetic Bone Void Filler in Tibial Plateau Fracture Fixation

March 2, 2026
·
3 min read
Press Releases

Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update

March 2, 2026
·
2 min read
Press Releases

Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference

March 2, 2026
·
4 min read
Press Releases

CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026

March 2, 2026
·
1 min read
Press Releases

BioSyent Announces Closing of the Acquisition of Oral Science Inc.

March 2, 2026
·
3 min read
Press Releases

Model Medicines to Highlight Two IND-Track Assets, Record-Setting AI Platform at BIO Investment & Growth Summit 2026

Company to spotlight its two lead drug candidates, MDL-001, a novel direct-acting antiviral targeting RdRp-Thumb 1, and MDL-4102, a novel transcriptional regulator targeting BRD4, both advancing toward IND.

March 2, 2026
·
1 min read
Press Releases

Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March

March 2, 2026
·
4 min read